The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Tuesday, February 08, 2022
Hoffmann-La Roche Limited (Roche Canada) announced that on January 14, 2022, Health Canada has authorized TECENTRIQ® (atezolizumab) as monotherapy for...
read more
Thursday, February 03, 2022
The FDA has issued a draft guidance for industry titled “Formal Meetings Between FDA and Sponsors or Requestors of Over-the-Counter Monograph Drugs.” ...
read more
Wednesday, February 02, 2022
German independent research institute BioMed X announced the extension of its collaboration with Merck KGaA, Darmstadt, Germany, in the research ...
read more
Wednesday, February 02, 2022
Eli Lilly and Company and Incyte announced updates on the Phase 3 development program for OLUMIANT® (baricitinib) in adults with active systemic lupus...
read more
Wednesday, February 02, 2022
Pfizer Inc. and BioNTech SE announced that following a request from the U.S. Food and Drug Administration (FDA) the companies have initiated a rolling...
read more
Wednesday, February 02, 2022
Navitor Pharmaceuticals announced that Janssen Pharmaceuticals has acquired Anakuria Therapeutics, Inc., a company recently formed by Navitor to ...
read more
Wednesday, February 02, 2022
ViiV Healthcare, the global specialist HIV company majority-owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. (Pfizer) and Shionogi Limited (...
read more
Wednesday, February 02, 2022
B. Braun Medical Inc. announced that the company has received final approval by the U.S. Food & Drug Administration (FDA) for its new pharmaceutical ...
read more
Wednesday, February 02, 2022
Takeda Pharmaceutical Company Limited announced that the U.S. Food & Drug Administration (FDA) approved VONVENDI® [von Willebrand factor (Recombinant)...
read more
Tuesday, February 01, 2022
Nordic Pharma announced that on the 24th of January, the European Commission (EC) approved the new indication for Teysuno® (tegafur/gimeracil/oteracil...
read more
Tuesday, February 01, 2022
Pfizer Inc. and Ionis Pharmaceuticals, Inc. announced the discontinuation of the Pfizer-led clinical development program for vupanorsen (PF-07285557),...
read more
Merck and Ridgeback Biotherapeutics announced data from six preclinical studies demonstrating that molnupiravir, an investigational oral antiviral ...
read more
As part of FDA’s efforts to help ensure Americans have access to compounded medicines when a patient’s medical needs cannot be met by an FDA-approved ...
read more
Regeneron Pharmaceuticals, Inc. and Sanofi announced the voluntary withdrawal of the supplemental Biologics License Application (sBLA) for Libtayo® (...
read more
Bristol Myers Squibb announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended ...
read more